FR EN
MI COMMUNITY
MI carries a strong voice for immunology research, freeing partners from their public or private sectors, breaking down disciplinary barriers and creating the essential conditions for acting together, quickly and sustainably

Emilie GARRIDO-PRADALIE
AP-HM

MI COMMUNITY
We and our patients are resolutely committed to the Marseille Immunopôle; patients no longer wish to be simple "providers of biological samples", but full participants in the research process.

Jean-Robert HARLÉ
AMU, AP-HM

MI COMMUNITY
Education is also one of the strategic components of the Marseille Immunopole project.

Françoise DIGNAT-GEORGE
AMU, AP-HM, C2VN

MI COMMUNITY
Today, the Covid-19 pandemic serves as an eye-opener, once again demonstrating the strength of the Marseille Immunopôle collective

Nassima CHOUAKI BENMANSOUR
AP-HM

MI COMMUNITY
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.

Éric VIVIER
AMU, AP-HM, CIML, INNATE PHARMA

MI COMMUNITY
Unique cluster in the world exclusively dedicated to basic and applied immunology, MI results from an efficient territorial game between research, industry, and the institutional stakeholders in economy and innovation.

Jacques PFISTER
CCI Marseille Provence

Newsletter
Stay informed
Subscribe
MI COMMUNITY
Our study models help to identify new potential therapeutic targets in preclinical models of personalized medicine.

Michel AURRAND-LIONS
AMU, IPC, CRCM

MI COMMUNITY
The laboratory's mission therefore reflects that of the Marseille Immunopôle: to lead the development of these innovations, from the initial discovery to the proof of concept in clinical setting.

Florence SABATIER
AMU, AP-HM

MI COMMUNITY
Each year, a large number of clinical trials are conducted by APHM clinicians alone or in partnership with industry players in biopharmaceuticals.

Frédéric VELY
AMU, AP-HM, CIML

MI COMMUNITY
Marseille Immunopole should allow us now to accelerate the development of therapeutic antibodies, the new drugs that are changing the course of cancer treatment.

Jean-Paul BORG
AMU, IPC, CRCM

Update on the umbrella clinical trial of the PIONeeR project as of February 28, 2023 Read more
MI COMMUNITY
Thanks to this unprecedented alliance of researchers, clinicians, technological platforms and industrials we should be able to quickly do much better

Vincent BARLOGIS
AP-HM

MI COMMUNITY
As such, we are involved in the Marseille immunology biotope

Michel MANCIS
Protisvalor

MI COMMUNITY
For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .

Nicolas SCHLEINITZ
AP-HM, AMU

MI COMMUNITY
“Histopathology is critical to establish a diagnosis based on microscopic tissue examination, but is also of great importance to medical research protocols such as The PIONeeR Project.”

Laurence BAGUR MISTRE
AP-HM